Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
November 30, 2025 0.0448M
August 31, 2025 -0.0627M
May 31, 2025 0.0075M
February 28, 2025 0.0118M
November 30, 2024 -0.0896M
August 31, 2024 -0.1122M
May 31, 2024 -0.2939M
February 29, 2024 -0.3438M
November 30, 2023 -0.2859M
August 31, 2023 -0.2232M
May 31, 2023 -0.1413M
February 28, 2023 -0.1369M
November 30, 2022 -0.1145M
August 31, 2022 -0.164M
May 31, 2022 -0.2503M
February 28, 2022 -0.3884M
November 30, 2021 -0.4905M
Date Value
August 31, 2021 -0.5048M
May 31, 2021 -0.5439M
February 28, 2021 -0.5172M
November 30, 2020 -0.6435M
August 31, 2020 -0.9675M
May 31, 2020 -1.306M
February 29, 2020 -1.802M
November 30, 2019 -2.450M
August 31, 2019 -2.543M
May 31, 2019 -2.509M
February 28, 2019 -2.339M
November 30, 2018 -1.504M
August 31, 2018 -1.266M
May 31, 2018 -1.202M
February 28, 2018 -0.9523M
November 30, 2017 -1.112M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Medifast, Inc. -0.026M
Integrated BioPharma, Inc. 1.241M
BioForce Nanosciences Holdings, Inc. -0.0419M
Skinvisible, Inc. 0.0038M
SkyTech Orion Global Corp. -0.571M